EPL (500135) Q4 24/25 earnings summary

Executive summary

• Q4 FY25 saw revenue growth of 7.4%, EBITDA up 17.7%, and adjusted PAT up 42.4% year-over-year, with 11 consecutive quarters of EBITDA margin above 20%.

• Full-year FY25 revenue grew 7.6%, EBITDA rose 17.5%, and adjusted PAT increased 44.6%; EPS improved to INR 11.38.

• 'Personal Care & Beyond' contributed 48% of tube revenue and led segment growth, outpacing Oral Care.

• Sustainability initiatives advanced, with 33% of the portfolio now recyclable and multiple awards for ESG leadership.

• Audited results approved with an unmodified opinion; final dividend of Rs. 2.50 per share recommended.

Financial highlights

• Q4FY25 revenue: INR 11,054 million (+7.4% YoY); EBITDA: INR 2,246 million (+17.7% YoY); EBITDA margin: 20.3%.

• FY25 consolidated revenue: Rs. 42,133 million, net profit after tax: Rs. 3,638 million; EPS: Rs. 11.27.

• Net debt-to-EBITDA improved to 0.54x; ROCE increased to 18%.

• Final dividend proposed at INR 5 per share and Rs. 2.50 per share recommended.

• Capex for FY25 at INR 3,631 million.

Outlook and guidance

• Confident of delivering double-digit growth and continued margin improvement in FY26.

• Focus on 'Personal Care & Beyond', Brazil and Thailand expansions, and sustainability to drive growth.

• CapEx for FY26 planned at INR 380-390 crore, supporting growth and greenfield projects.

• Minimal impact expected from U.S. tariffs due to local manufacturing and contractual pass-throughs.

• Investment in a new wholly owned subsidiary in Thailand post year-end.